Method for the Reduction of Dangerous Blood Sugar Levels

Abstract

The present invention relates to a method and procedure for reducing immediate serum glucose levels without resort to drugs. Specifically, the invention discloses a regular regimen comprising modest exercise, daily nutritional supplements and a series of specific, time sensitive steps, which, when followed will optimize the effects of the invention.

Claims

1. A composition for supplementing daily nutritional chromium, said composition comprising a chromium complex in combination with niacin, L-Arginine, or both niacin and L-Arginine.

2. The composition of claim 1, further comprising at least one vasodilator wherein said vasodilator is aspirin.

3. The composition if claim 1, wherein said chromium complex is selected from the group consisting of chromium picolinate, chromium nicotinate, chromium glycinate, or other chromium comprising chromium content of between about 100 to 500 micrograms.

4. A method for supplementing daily nutritional chromium in a person, said method comprising administering to said person a composition in an effective amount of chromium complex in combination with niacin, L-Arginine, or both niacin and L-Arginine.

5. The method of claim 4, wherein said effective amount of chromium complex is between about 100 to 1,500 micrograms.

6. The composition of claim 4, wherein said chromium complex is selected from the group consisting of chromium picolinate, chromium nicotinate, chromium glycinate, or other chromium comprising chromium content of between about 100 to 500 micrograms.

7. The method of claim 4, wherein said composition is administered orally, nasally, sublingually, intramuscularly, subcultaneously, and transdermally.

8. A method for reducing blood serum glucose in a person in need thereof, comprising administering to said person a composition in an effective amount of chromium complex in combination with niacin, L-Arginine, or both niacin and L-Arginine.

9. The method of claim 8, wherein the effective amount of chromium complex is between about 100 to 1,500 micrograms.

10. The composition if claim 8, wherein said chromium complex is selected from the group consisting of chromium picolinate, chromium nicotinate, chromium glycinate, or other chromium comprising chromium content of between about 100 to 500 micrograms.

11. The method of claim 8, wherein said composition is administered orally, nasally, sublingually, intramuscularly, subcultaneously, and transdermally.

Description

[0029] Preferred Embodiment. The invention consists of components which give Type II Diabetics the ability to effect dramatic, short-term reduction of blood sugar levels and to eventually replenish the body's stores of Chromium (III) The components are as follows [0030] a. A daily regimen of vitamins and tablets comprising [0031] i Twice daily doses of a compound comprising the Chromium complex of an Organic Acid such as Picolinate, Nicotinate, Glycinate or other having a chromium content of between 100 and 500 micrograms of Chromium. [0032] ii. 200-1,000 milligram daily dose of a vasa-dilator/blood thinner comprising aspirin, niacin and L-Arginine [0033] iii. doses of liquid Ionic chromium in the concentration of between 100500 parts per million, such that each dose contains between 100 and 1,500 micrograms of chromium. Such compound is administered in a fashion which will introduce massive amounts of Cr(III) into the blood stream in a rapid manner, such as sublingually. [0034] b. A complimentary exercise regimen comprising at least one daily aerobic exercise session of at least one-half hour each. The exercise should elevate and hold the heart rate at or above 60% of the maximum as established by the American Medical Association for the duration of the workout. [0035] c. A method of administering the daily regimen: [0036] i. The Chromium Organic acid compound is ingested at least twice per day usually in the morning and in the evening. [0037] ii. Approximately 10 minutes prior to each work out, the person ingests the vasodilator/blood thinner. [0038] iii. Immediately prior to workout, the person places the Ionic Chromium complex under the tongue (sublingual) and holds it there during the exercise for as long as possible before swallowing. [0039] iv. Approximately mid-way through the work out, the person repeats the sublingual administration of the Ionic Chromium complex.

Closest Known Prior Art

[0040]

TABLE-US-00001 Patent No. Inventor Date Title 4,571,391 RileY, et al Feb. 18, 1986 Chromium acetylacetonate as a dietary supplement and pharmaceutical agent 4,954,492 Jensen Sep. 4, 1990 Synthetic GTF chromium material for decreasing blood lipid levels and process therefor 4,923,855 Jensen May 8, 1990 Synthetic GTF chromium material and process therefor 5,087,623 Boynton, et al Feb. 11, 1992 Chromic picolinate treatment 5,087,624 Boynton, et al Feb. 11, 1992 Chromic picolinate treatment 5,194,615 Jensen Mar. 16, 1993 Synthetic GTF chromium nicotinate material and its preparation 5,567,736 Buchman, et al Oct. 22, 1996 Use of a choline salt to inhibit fatty liver al 1996 in patients receiving total parenteral nutrition 5,905,075 Harpe, et al May 18, 1999 Chromium nicotinate composition and uses thereof 5,948,772 de la Harpe, et al Sep. 7, 1999 Chromium picolinate compositions and uses thereof 5,962,030 Fine Oct. 5, 1999 Dietary supplement and method of treatment for diabetic control Chromium 5,980,905 de la Harpe, et al Nov. 9, 1999 Chromium polynicotinate compositions and uses thereof 6,093,711 de la Harpe, et al Jul. 25, 2000 Enteric-coated chromium picolinate compositions and uses thereof 6,100,250 de la Harpe, et al Aug. 8, 2000 Enteric-coated chromium polynicotinate compositions and uses thereof 6,100,251 de la Harpe, et al Aug. 8, 2000 Chromium polynicotinate compositions 6,136,317 de la Harpe, et al Oct. 24, 2000 Chromium polynicotinate compositions 6,143,301 de la Harpe, et al Nov. 7, 2000 Chromium picolinate compositions and uses thereof 6,147,070 Facchini Nov. 14, 2000 Methods and compositions for controlling iron stores to treat and cure disease states 6,203,819 Fine Mar. 20, 2001 Dietary supplement and method of treatment for diabetic control 6,251,888 de la Harpe, et al Jun. 26, 2001 Chromium picolinate compositions and uses thereof 6,251,889 de la Harpe, et al Jun. 26, 2001 Chromium polynicotinate compositions 6,258,848 Fantus Jul. 10, 2001 Methods and compositions for increasing insulin sensitivity 6,323,192 Harpe, et al Nov. 27, 2001 Chromium polynicotinate compositions and uses thereof for absorption of essential metals 6,432,942 de la Harpe, et al Aug. 13, 2002 Chromium picolinate compositions and uses thereof 6,440,931 Remmereit, et al Aug. 13, 2002 Conjugated linoleic acid in treatment and prophylaxis of diabetes 6,471,998 de la Harpe, et al Oct. 29, 2002 Chromium polynicotinate compositions 6,541,005 Yegorova Apr. 1, 2003 Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis 6,544,525 Yegorova Apr. 18, 2003 Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis 6,548,687 Yu, et al Apr. 15, 2003 Chromium L-threonate, process for preparation of the same and their use 6,576,242 Yegorova Jun. 10, 2003 Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis 6,576,242 Giordana, et al Dec. 9, 2003 Compositions and methods for prophylactic and therapeutic supplementation of nutrition in subjects 6,689,383 Anderson, et al Feb. 10, 2004 Chromium-histidine complexes as nutrient supplements 6,713,469 de la Harpe, et al Mar. 30, 2004 Chromium picolinate compositions and uses thereof 6,809,115 Kartz, et al Oct. 26, 2004 Methods and compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols 6,814,983 Giordana, et al Nov. 9, 2004 Compositions and methods for nutrition supplementation 6,818,229 Cefali, et al Nov. 16, 2004 Intermediate release nicotinic acid compositions for treating hyperlipidemia 6,818,223 Perkes Nov. 16, 2004 Dietary supplements containing natural ingredients 6,852,690 Nauck, et al Feb. 8, 2004 Method and composition for enhanced parenteral nutrition 6,852,760 Nauck, et al Feb. 8, 2004 Compositions and methods for treatment for glucose metabolism disorders 6,893,627 Ribnicky, et al Feb. 8, 2004 Method for treating type 2 diabetes with an extract of Artemisia 6,893,627 Blitzer, et al May 17, 2005 Athletic patch 6,955,883 Margus, et al Oct. 18, 2005 Life sciences business systems and Methods 6,967,030 Wright, et al Nov. 22, 2005 Formulation for insulin and glucose control 6,967,204 Friburg, et al Nov. 22, 2005 Treatment of insulin resistance syndrome and type 2 diabetes with PDE9 inhibitors 6,995,166 Giordano, et al Feb. 7, 2006 Method and composition for supplementation of nutritional deficiencies in renal patients